A specific protein in the body may be the key to overcoming the increasing problem of resistance to HIV drugs, researchers say.
HIV drugs known as protease inhibitors has been suggested by a team of researchers from Harvard Medical School, Boston, and Inserm U848, France, as a result of their work in a mouse model of retinal ...
... tiny bits of gold to a failed HIV drug rekindle the drug’s ability to stop the virus ... testing, they found that attaching 12 molecules of the modified drug (SDC-1721) to one nanoparticle of gold restored ...
... t work as well as it should is resistance to the drugs involved. Now, scientists at McGill University ... genotype testing is now widely established in HIV drug resistance screening. However, for technical ...
... Disheartened by the failures of vaccines and microbicides in blocking HIV transmission, some AIDS researchers are now touting a third possibility: using existing HIV drugs prophylactically.
... of therapeutic agents against HIV, factors that dictate the pharmacokinetics of anti-HIV drugs need to be accounted for in order to have HAART efficacy in sequestered viral reservoirs. Several P-gp ...
... T-cell, binding to it in such a way that prevents HIV from binding and subsequently infecting the T-cell. ... resistance, medicines lose their ability to fight HIV. Some drugs become less effective while ...
... every human cell. It is capable of stopping HIV at the first step of replication, when the retrovirus transcribes ... understanding provides a platform for designing anti-HIV drugs."
If APOBEC-3G works so ...
... adherence to life saving antiretroviral drugs among African HIV patients should be understood ... Sub-Saharan Africa, adherence to these anti-HIV drugs improves patients' health, which is also a strong ...
ROME, Feb. 2 (UPI) -- The co-discoverer of the HIV virus, Luc Montagnier, says poor nations need better access to HIV drugs.
... immune system surveillance and escape from anti-HIV drugs.
"Macrophages are these little factories producing ... various AIDS-related conditions, including HIV-associated dementia, non-Hodgkin's lymphoma ...
WASHINGTON (AP) -- The Food and Drug Administration says an HIV drug from Pfizer appears safe for expanded use in patients who have not taken other drugs to combat the virus....
... show promise as novel treatments for the disease. HIV drug discovery efforts have met with little ... so-called "accessory proteins" encoded by HIV which are important virulence factors in AIDS. Inhibitory ...
... Their work was published this week in Cell.
"Many anti-HIV drugs are designed to stop the process of DNA ... a long time," says Yin. "Dosages and combinations of drugs can be chosen so they don't kill ...
... enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both ... inhibitors (NNRTIs), a major class of anti-HIV drugs. Abbondanzieri and coworkers observed NNRTIs ...
